Table 3.

Correlation between paralogous group 13 (HOXA-HOXB-HOXC-HOXD) expression and main clinical features of 94 patients

Main clinical-pathological characteristics		HOXA13		Pearson Chi-Square	Pearson’s R	HOXB13		Pearson Chi-Square	Pearson’s R	HOXC13		Pearson Chi-Square	Pearson’s R	HOXD13		Pearson Chi-Square	Pearson’s R
		Weak or Negative expression	Positive expression			Weak or Negative expression	Positive expression			Weak or Negative expression	Positive expression			Weak or Negative expression	Positive expression
Age	≤68	36.7%	63.3%	0.512	0.083	24.5%	75.5%	0.315	0.111	49.0%	51.0%	0.146	0.159	20.4%	79.6%	0.113	-0.169
	>69	28.9%	71.1%			15.6%	84.4%			33.3%	66.7%			35.6%	64.4%
Gender	F	35.7%	64.3%	0.811	0.038	21.4%	78.6%	1	0.020	64.3%	35.7%	0.006	0.301	17.9%	82.1%	0.212	-0.143
	M	31.8%	68.2%			19.7%	80.3%			31.8%	68.2v			31.8%	68.2%
Site	Lip	0	100%	0.624	-0.061	0	100%	0.319	0.072	0	100%	0.345	-0.029	0	100%	0.427	0.038
	Tongue	33.9%	66.1%			25%	75%			44.6%	55.4%			32.1%	67.9%
	Other	34.3%	65.7%			14.3%	85.7%			40%	60%			22.9%	77.1%
Deep invasion	≤5	26.7%	73.3%	0.766	-0.093	20%	80%	1	-0.002	66.7%	33.3%	0.045	0.223	20%	80%	0.548	-0.075
	>6	34.2%	65.8%			20.3%	79.7%			36.7%	63.3%			29.1%	70.9%
Grading	1	16.7%	83.3%	0.236	-0.093	27.8%	72.2%	0.541	0.114	38.9%	61.1%	1	-0.114	27.8%	72.2%	1	0.004
	2	38.9%	61.1%			20.4%	79.6%			42.6%	57.4%			27.8%	72.2%
	3	31.8%	68.2%			13.6%	86.4%			40.9%	59.1%			27.3%	72.7%
T	1	31.3%	68.8%	0.406	-0.003	25%	75%	0.544	0.144	50%	50%	0.284	0.031	43.8%	56.3%	0.261	0.204
	2	37.5%	62.5%			25%	75%			42.5%	57.5%			30%	70%
	3	16.7%	83.3%			16.7%	83.3%			22.2%	77.8%			22.2%	77.8%
	4	40%	60%			10%	90%			50%	50%			15%	85%
Staging	1	20%	80%	0.217	-0.094	30%	70%	0.749	0.107	50%	50%	0.908	0.049	50%	50%	0.224	0.180
	2	39.1%	60.9%			21.7%	78.3%			39.1%	60.9%			34.8%	65.2%
	3	18.2%	81.8%			22.7%	77.3%			45.5%	54.5%			18.2%	81.8%
	4	41%	59%			15.4%	84.6%			38.5%	61.5%			23.1%	76.9%